Ulcerative Colitis Clinical Trials Ulcerative Colitis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Condition:   Ulcerative Colitis Interventions:   Drug: Tilpisertib Fosmecarbil;   Drug: Placebo Sponsor:   Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials